155 related articles for article (PubMed ID: 34666013)
1. Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study.
Arnold SV; Khunti K; Tang F; Chen H; Cid-Ruzafa J; Cooper A; Fenici P; Gomes MB; Hammar N; Ji L; Saraiva GL; Medina J; Nicolucci A; Ramirez L; Rathmann W; Shestakova MV; Shimomura I; Surmont F; Vora J; Watada H; Kosiborod M
Am Heart J; 2022 Jan; 243():232-239. PubMed ID: 34666013
[TBL] [Abstract][Full Text] [Related]
2. Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program).
Kosiborod M; Gomes MB; Nicolucci A; Pocock S; Rathmann W; Shestakova MV; Watada H; Shimomura I; Chen H; Cid-Ruzafa J; Fenici P; Hammar N; Surmont F; Tang F; Khunti K;
Cardiovasc Diabetol; 2018 Nov; 17(1):150. PubMed ID: 30486889
[TBL] [Abstract][Full Text] [Related]
3. BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study.
Polemiti E; Baudry J; Kuxhaus O; Jäger S; Bergmann MM; Weikert C; Schulze MB
Diabetologia; 2021 Apr; 64(4):814-825. PubMed ID: 33452586
[TBL] [Abstract][Full Text] [Related]
4. Impact of micro- and macrovascular complications of type 2 diabetes on quality of life: Insights from the DISCOVER prospective cohort study.
Arnold SV; Khunti K; Tang F; Chen H; Nicolucci A; Gomes MB; Ji L; Shestakova MV; Watada H; Cooper A; Fenici P; Hammar N; Medina J; Kosiborod M;
Endocrinol Diabetes Metab; 2022 Mar; 5(2):e00321. PubMed ID: 35029066
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: A cross-sectional baseline study of 6958 patients in the Danish DD2 cohort.
Gedebjerg A; Almdal TP; Berencsi K; Rungby J; Nielsen JS; Witte DR; Friborg S; Brandslund I; Vaag A; Beck-Nielsen H; Sørensen HT; Thomsen RW
J Diabetes Complications; 2018 Jan; 32(1):34-40. PubMed ID: 29107454
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular health metrics defined by Life's Essential 8 scores and subsequent macrovascular and microvascular complications in individuals with type 2 diabetes: A prospective cohort study.
Huang ZG; Gao JW; Zhang HF; You S; Xiong ZC; Wu YB; Guo DC; Wang JF; Chen YX; Zhang SL; Liu PM
Diabetes Obes Metab; 2024 Jul; 26(7):2673-2683. PubMed ID: 38558498
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes.
An J; Nichols GA; Qian L; Munis MA; Harrison TN; Li Z; Wei R; Weiss T; Rajpathak S; Reynolds K
BMJ Open Diabetes Res Care; 2021 Jan; 9(1):. PubMed ID: 33397671
[TBL] [Abstract][Full Text] [Related]
8. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
Grauslund J
Acta Ophthalmol; 2011 Feb; 89 Thesis 1():1-19. PubMed ID: 21443578
[TBL] [Abstract][Full Text] [Related]
9. Risk of future microvascular and macrovascular disease in people with Type 1 diabetes of very long duration: a national study with 10-year follow-up.
Adamsson Eryd S; Svensson AM; Franzén S; Eliasson B; Nilsson PM; Gudbjörnsdottir S
Diabet Med; 2017 Mar; 34(3):411-418. PubMed ID: 27647178
[TBL] [Abstract][Full Text] [Related]
10. Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes.
Herrmann M; Sullivan DR; Veillard AS; McCorquodale T; Straub IR; Scott R; Laakso M; Topliss D; Jenkins AJ; Blankenberg S; Burton A; Keech AC;
Diabetes Care; 2015 Mar; 38(3):521-8. PubMed ID: 25524951
[TBL] [Abstract][Full Text] [Related]
11. Incidence of complications and mortality in a type 2 diabetes patient cohort study followed up from diagnosis in a primary healthcare centre.
Mata-Cases M; De Prado-Lacueva C; Salido-Valencia V; Fernández-Bertolín E; Casermeiro-Cortés J; García-Durán M; Jabalera-López S; Fernández-Sanmartín MI
Int J Clin Pract; 2011 Mar; 65(3):299-307. PubMed ID: 21314867
[TBL] [Abstract][Full Text] [Related]
12. Microvascular and macrovascular complications in type 2 diabetes Ghanaian residents in Ghana and Europe: The RODAM study.
Hayfron-Benjamin C; van den Born BJ; Maitland-van der Zee AH; Amoah AGB; Meeks KAC; Klipstein-Grobusch K; Bahendeka S; Spranger J; Danquah I; Mockenhaupt F; Beune E; Smeeth L; Agyemang C
J Diabetes Complications; 2019 Aug; 33(8):572-578. PubMed ID: 31167710
[TBL] [Abstract][Full Text] [Related]
13. Macrovascular and microvascular disease in obese patients with type 2 diabetes attending structured diabetes education program: a population-based propensity-matched cohort analysis of Patient Empowerment Programme (PEP).
Wong CK; Wong WC; Wan EY; Chan AK; Chan FW; Lam CL
Endocrine; 2016 Aug; 53(2):412-22. PubMed ID: 26785847
[TBL] [Abstract][Full Text] [Related]
14. Sex difference in the incidence of microvascular complications in patients with type 2 diabetes mellitus: a prospective cohort study.
Singh SS; Roeters-van Lennep JE; Lemmers RFH; van Herpt TTW; Lieverse AG; Sijbrands EJG; van Hoek M
Acta Diabetol; 2020 Jun; 57(6):725-732. PubMed ID: 32025877
[TBL] [Abstract][Full Text] [Related]
15. Preserved Ratio Impaired Spirometry and Risks of Macrovascular, Microvascular Complications and Mortality Among Individuals With Type 2 Diabetes.
Li G; Jankowich MD; Wu L; Lu Y; Shao L; Lu X; Fan Y; Pan CW; Wu Y; Ke C
Chest; 2023 Nov; 164(5):1268-1280. PubMed ID: 37356807
[TBL] [Abstract][Full Text] [Related]
16. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes.
Zoungas S; Woodward M; Li Q; Cooper ME; Hamet P; Harrap S; Heller S; Marre M; Patel A; Poulter N; Williams B; Chalmers J;
Diabetologia; 2014 Dec; 57(12):2465-74. PubMed ID: 25226881
[TBL] [Abstract][Full Text] [Related]
17. Macrovascular and microvascular outcomes after beginning of insulin versus additional oral glucose-lowering therapy in people with type 2 diabetes: an observational study.
Hall GC; McMahon AD; Carroll D; Home PD
Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):305-13. PubMed ID: 22271442
[TBL] [Abstract][Full Text] [Related]
18. Impact of bariatric surgery on the development of diabetic microvascular and macrovascular complications.
Goldberg I; Nie L; Yang J; Docimo S; Obici S; Talamini M; Pryor A; Spaniolas K
Surg Endosc; 2021 Jul; 35(7):3923-3931. PubMed ID: 32748271
[TBL] [Abstract][Full Text] [Related]
19. Causes of in-hospital death in patients with type 2 diabetes with microvascular and macrovascular complications in Taiwan.
Tu CL; Sue SP; Hsu WH; Huang HY; Wen WL; Lin IT; Chen KH; Sheu NW; Huang SH; Lee MY
Int J Clin Pract; 2021 Oct; 75(10):e14491. PubMed ID: 34115914
[TBL] [Abstract][Full Text] [Related]
20. Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre study.
Noordzij MJ; Mulder DJ; Oomen PH; Brouwer T; Jager J; Castro Cabezas M; Lefrandt JD; Smit AJ
Diabet Med; 2012 Dec; 29(12):1556-61. PubMed ID: 22937960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
